Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Indu... (rdiscontinuation of their chemotherapy r...)

Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia

Date:1/25/2008

r discontinuation of their chemotherapy regimen, the occurrence of dose limiting toxicity, documented disease progression, or change in chemotherapy regimen.

The trial will evaluate the safety, pharmacokinetics and preliminary efficacy of various doses of Hematide in the correction of anemia. Initial dosing in this trial is based on results from an earlier trial in a more heterogeneous population of cancer patients that was conducted by Affymax in Europe in 2006. This new U.S. trial will aid in the selection of the appropriate dose or doses to be used in this more homogeneous patient population in additional later stage clinical trials.

About Hematide

Hematide is a novel synthetic, pegylated peptidic compound that binds to and activates the erythropoietin receptor and acts as an erythropoiesis stimulating agent. The product is being developed for treatment of anemia in patients with chronic renal failure and cancer patients receiving chemotherapy.

About Takeda

Located in Osaka, Japan, Takeda (TSE: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, http://www.takeda.com.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide(TM), is currently being evaluated in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure and is in clinical trials for the treatment of chemotherapy-induced anemia in cancer patients. For additional information, please visit
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
2. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
3. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
4. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
5. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
11. Tainted Chinese Food Ingredients First Discovered in 2005

Post Your Comments:

(Date:12/15/2009)... find the best plan at the right price ... the end of the year, thousands of Nebraska Medicare ... coverage. This is when the state,s 268,000 Medicare ... sign up and pay for in 2010. ,, ... decision, says Independent Retail Pharmacist Steve Osenbaugh, of Lincoln. ...

(Date:12/15/2009)... Dec. 15 Fenwal Inc., a global ... separation, safety and availability, announced today that the ... approval to market InterSol ® platelet additive ... solution is a specialized product used in combination ... vital blood component used to prevent or treat ...

(Date:12/15/2009)... ,, Reportlinker.com announces that a ... its catalogue: ,, Hepatitis B Vaccines ... 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, ... Market Forecasts to 2015 ,, Summary ... new report, "Hepatitis B Vaccines - Pipeline ...

[0] Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans [0] Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets [0] Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015

... a national study to explore new IVF progesterone ... Reproductive Partners Medical Group a ... excellent IVF success rates and national reputation was ... multi-center study exploring new progesterone delivery systems to ...

... CAMBRIDGE, Mass., Jan. 12 Idenix Pharmaceuticals, Inc. (Nasdaq: ... the discovery and development of drugs for the treatment ... that it has initiated a proof-of-concept study of IDX184, ... HCV under an Investigational New Drug application (IND) with ...

Other Medicine Technology:Reproductive Partners Participates in New IVF Progesterone Delivery System Study 2 Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 2 Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 3 Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 4

Reproductive Partners Participates in New IVF Progesterone Delivery System Study Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

(Date:12/15/2009)... PARK, Calif., Dec. 15 ... position in the pharmaceutical and bio-tech research ... Marketing Research). Over the past 11 years ... the Physicians Consulting Network (PCN®), which now ... professionals covering both primary care and hard-to-reach ...

(Date:12/15/2009)... 15 The following are the remarks ... the criminal division, at the Medicare Fraud Strike ... And thank you for the enormous effort everyone ... ,, Together, our Departments have and will ... We,ve made tremendous progress in fighting Medicare fraud ...

(Date:12/15/2009)... CHAMPAIGN, lll. Physical activity is known to reduce ... A new study indicates that this effect stems from ... in his or her ability to achieve certain ... Psychosomatic Medicine . , "We base our arguments ... McAuley, a professor of kinesiology and community health at ...

(Date:12/15/2009)... help, experts say , , TUESDAY, Dec. 15 (HealthDay News) ... how to spot the signs of stroke in relatives ... , Emergency medical treatment within three hours of the ... damage and lead to better recovery. , The Kids ... graders in Texas who were divided into two groups. ...

(Date:12/15/2009)... launches SafeConsole 4.0, the web management software for SafeStick, the ... better usability for employees and more control for administrators through ... , ... Washington, DC (PRWEB) December ... of secure USB devices, today launches SafeConsole 4.0, the web ...

Breaking Medicine News(10 mins):Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2 Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2 Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3 Health News:Mastery of physical goals lessens disease-related depression and fatigue 2 Health News:Boosting Kids' Stroke IQ May Save Lives 2 Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2 Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3

[1] Knowledge Networks Expands in Pharma Research With Acquisition of CMR [1] Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference [0] Mastery of physical goals lessens disease-related depression and fatigue [0] Boosting Kids' Stroke IQ May Save Lives [0] BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices

... Program Gets Children to Eat More ... ... Antine, MS, RD and,founder of HealthBarn(R) USA was honored today on ... Eating series sponsored by The,American Egg Board (http://www.rachaelrayshow.com/incrediblepeople/ ). Antine ...

... of Redondo,Beach, California, had no idea that she ... and stop the production of one of the ... -- asbestos. Reinstein is,executive director and co-founder of ... international organization,that serves as a voice for all ...

... of Nottingham say modern matrons with their managerial ... role as leader, and this remains a major challenge ... at the Institute for Science and Society say modern ... budgetary responsibility is made part of the role, personal ...

... Event for Advanced ... ... Systems, Inc.,provider of Plexus Online on-demand software for the manufacturing,enterprise, ... and Conference in Charlotte, North Carolina on,March 19-20., (Logo: ...

... an address to,the Council of Teaching Hospitals in New ... health and wellness, Dr. John,Agwunobi will confirm a major ... in September 2006, the program has now saved,Americans more ... In his prepared remarks, Agwunobi will mention that ...

... But stress linked to shorter life for men, study finds ... may help elderly women live longer, but may harm older ... the Cleveland Clinic and Case Western Reserve University followed 1,000 ... years. , They found that women with higher levels of ...

Other Medicine News:Health News:HealthBarn(R) USA Founder Shares Secrets For Healthy Eating With Rachael Ray 2 Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 2 Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 3 Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 4 Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 5 Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 6 Health News:Modern matron struggling to fulfil role as leader 2 Health News:Plexus Systems, Inc. Announces Participation at AM EXPO 2 Health News:Wal-Mart Saves Customers More Than $1 Billion On Prescription Drugs 2 Health News:Anxiety Helps Elderly Women Live Longer 2

HealthBarn(R) USA Founder Shares Secrets For Healthy Eating With Rachael Ray ADAO's March 29 Conference Unites Survivors, Families and Physicians Modern matron struggling to fulfil role as leader Plexus Systems, Inc. Announces Participation at AM EXPO Wal-Mart Saves Customers More Than $1 Billion On Prescription Drugs Anxiety Helps Elderly Women Live Longer

Inquire...

Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....

... Use the Mo Bio Vortex Adapter in ... bead beating procedures. Using the Mo Bio ... bead beating and Fast Prep machines which offer ... 4 (15 ml) centrifuge tubes at one time ...

... Combines BchiVac V-500 with Vacuum Controller V-800 and ... levels from Compact Housing ... pump designed to handle most vacuum applications. ... up to two rotary evaporators Laboratory ...

Medicine Products:

Labnet Vortex (220V)Vortex adapter, for Labnet vortex, holds 2 each 50 ml tubes Vortex Adapter for Vortex Genie 2, holds (4) 15 ml tubes Clean Air Vacuum System V-513, 230V

Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Indu...(rdiscontinuation of their chemotherapy r...),Health